Moon Capital Management (Tennessee)’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-6,331
Closed -$235K 47
2019
Q4
$235K Buy
+6,331
New +$226K 0.24% 44
2019
Q3
Sell
-5,710
Closed -$235K 47
2019
Q2
$235K Hold
5,710
0.25% 41
2019
Q1
$230K Hold
5,710
0.26% 42
2018
Q4
$236K Hold
5,710
0.3% 41
2018
Q3
$240K Buy
+5,710
New +$220K 0.24% 42
2018
Q1
Sell
-5,710
Closed -$196K 49
2017
Q4
$196K Buy
+5,710
New +$195K 0.2% 50
2017
Q1
Sell
-7,101
Closed -$219K 43
2016
Q4
$219K Hold
7,101
0.34% 36
2016
Q3
$228K Hold
7,101
0.32% 37
2016
Q2
$237K Buy
+7,101
New +$227K 0.3% 40
2016
Q1
Sell
-7,101
Closed -$217K 49
2015
Q4
$217K Buy
+7,101
New +$223K 0.29% 40
2015
Q3
Sell
-6,380
Closed -$203K 39
2015
Q2
$203K Buy
6,380
+246
+4% +$8.02K 0.28% 35
2015
Q1
$202K Buy
+6,134
New +$195K 0.31% 35

Other funds holding PFE

Moon Capital Management (Tennessee)'s PFE Position: Q1 2020 in Review

Moon Capital Management (Tennessee) sold out of Pfizer (PFE) in Q1 2020, closing a stake of 6,331 shares — an estimated $235K sold.

Moon Capital Management (Tennessee) first reported a position in PFE in Q1 2015 and held it in 12 quarters. The position peaked at $240K in Q3 2018. 2,437 funds tracked by Wall St. Rank hold PFE as of Q1 2020.

  • Moon Capital Management (Tennessee) reported no remaining Pfizer position as of Q1 2020 after selling out during the quarter.
  • Moon Capital Management (Tennessee) sold 6,331 Pfizer shares in Q1 2020, an estimated $235K.
  • Moon Capital Management (Tennessee) first reported a position in Pfizer in Q1 2015 and held it in 12 quarters.
  • Moon Capital Management (Tennessee)'s Pfizer position peaked at $240K in Q3 2018.
  • 2,437 funds tracked by Wall St. Rank held Pfizer as of Q1 2020.

Based on Moon Capital Management (Tennessee)'s 13F filing for Q1 2020, filed 15 Apr 2020.